Clinical Trials Directory

Trials / Conditions / Stage IIA Pancreatic Cancer

Stage IIA Pancreatic Cancer

19 registered clinical trials studyying Stage IIA Pancreatic Cancer.

StatusTrialSponsorPhase
Active Not RecruitingTrametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer
NCT03825289
University of UtahPhase 1
CompletedVX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer
NCT03373188
Emory UniversityPhase 1
CompletedHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
NCT03154190
Stanford UniversityN/A
TerminatedPreoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study
NCT02345460
Case Comprehensive Cancer CenterPhase 2
CompletedElectronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in P
NCT02511821
City of Hope Medical CenterN/A
CompletedNeoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Canc
NCT02349867
Virginia Commonwealth UniversityPhase 1
CompletedPalliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer
NCT02307539
City of Hope Medical CenterN/A
CompletedNeoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer
NCT01918644
University of Wisconsin, MadisonPhase 1
CompletedCombination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer
NCT02047474
Yale UniversityPhase 2
WithdrawnMetformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery
NCT01954732
Case Comprehensive Cancer CenterPhase 1
WithdrawnPatient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancr
NCT02414100
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University—
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
CompletedChemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer
NCT01959672
University of NebraskaPhase 2
TerminatedGemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer
NCT01897454
Albert Einstein College of MedicinePhase 2
CompletedDasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreati
NCT01234935
Translational Oncology Research InternationalPhase 2
TerminatedRO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
NCT01192763
National Cancer Institute (NCI)Phase 1
CompletedPerioperative Therapy for Resectable Pancreatic Cancer
NCT00609336
University of WashingtonPhase 2
TerminatedErlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
NCT00482625
National Cancer Institute (NCI)Phase 2
CompletedBevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patien
NCT00305877
National Cancer Institute (NCI)Phase 2